FDA approved lisocabtagene maraleucel (Breyanzi, Juno Therapeutics) for adult patients with refractory large B-cell
#lymphoma
(LBCL).
#lymsm
#OCENewsBurst
Which is the correct symbol for Medicine?
Rod of Asclepius or Staff of Hermes (Caduceus)?
Let's talk about the extremely common and embarrassingly incorrect symbol that is used in India (and the rest of the world) and why it frustrates me.
#MedTwitter
#ChooseWordsWisely
A few more-
Pts with cancer
NOT cancer pts
Why do we write-
pt reports symptoms
Why not just say-
pt has symptoms
And my personal request-
Replace male/female with man/woman
It just sounds so much nicer and human.
#LetsKeepTrying
After lots of opinions on SHINE and lots have asked my view, here is a brief thread with a few thoughts:
1. Congratulations to the authors. MCL is uncommon and not easy to perform very large randomised trials in - its a huge effort that should be celebrated and recognised.
#ChooseWordsWisely
A few more-
Pts with cancer
NOT cancer pts
Why do we write-
pt reports symptoms
Why not just say-
pt has symptoms
And my personal request-
Replace male/female with man/woman
It just sounds so much nicer and human.
#LetsKeepTrying
#ChooseWordsWisely
Humble request to expert speakers everywhere.
Pts don't relapse
Disease relapses
Pts with R/R disease
NOT R/R pts
Pts didn't fail therapies
Therapies failed pts
Yes, it takes effort and time to change habits, but we must keep trying.
#ASCO22
#EHA2022
Yesterday at the hospital, a man said to me, I hear my country in your voice. I have been thinking about it ever since. He didn’t say, like a typical American, you have an accent. He placed an entire country in my being & in so doing walked both of us into this communal space.
#CLL13
online
CIT (150 FCR 79 BR) RV 237 GV 229 GIV 231
2nd co-endpt met
GIVe⬆️PFS vs CIT HR 0.32
G-Ven⬆️PFS vs CIT HR 0.42
PFS not diff: RV vs CIT
3Y PFS
91% GIVe
88% GV
81% RV
75% CIT
✅driven by IGHV unmut
#CLL
OS similar
⬆️SM in FCR/BR
ven-O⬆️PFS vs FCR/BR in fit pts
#EHA22
#ChooseWordsWisely
Humble request to expert speakers everywhere.
Pts don't relapse
Disease relapses
Pts with R/R disease
NOT R/R pts
Pts didn't fail therapies
Therapies failed pts
Yes, it takes effort and time to change habits, but we must keep trying.
#ASCO22
#EHA2022
#ASCO22
Concluding thoughts:
So much amazing science was presented
@ASCO
last week. We must never forget that failure is 100% a part of research. Figuring out what does and does not work is essential. Presenting and publishing negative trials is important.✅
#ThatIsScience
My thoughts on the DETERMINATION trial in myeloma presented in the Plenary session of
#ASCO22
and published simultaneously in
@NEJM
#ASCO22VR
1) This is not a trial of transplant vs no transplant.
2) It's ~ the 5th RCT of early vs delayed transplant